Tight Junctions and the Skin Barrier — What They Are, Where They Sit, and Why They Matter
The stratum corneum and its lipid matrix have dominated how skincare talks about the skin barrier. That conversation is incomplete. Below the stratum corneum, in a layer of skin the industry has largely ignored, a second structural system regulates what passes through the skin from the inside out and from the outside in.
That system is tight junctions. This article explains what they are, where they are located, what they do — and why understanding the skin barrier requires understanding both structural systems at once.
What tight junctions are
Tight junctions are protein structures that seal the gaps between adjacent cells — and in skin, they form a continuous barrier within a specific layer of the epidermis.
Every living tissue in the body faces a version of the same problem: individual cells must sit next to one another without leaving gaps that allow molecules to pass freely between them. If those gaps were uncontrolled, the body could not regulate what moved across any of its surfaces — gut, kidney, lung, or skin. The solution, in all of these tissues, is the tight junction.
A tight junction is a protein complex that forms at the point where two adjacent cells touch. It does not weld the cells together. Instead, it creates a seal at that contact point — a regulated closure that allows the tissue to control what crosses the space between cells, rather than leaving that space as an open channel.
A tight junction is a multiprotein complex that forms at the lateral contact zone between adjacent epithelial or epidermal cells. It consists of transmembrane proteins — primarily claudins and occludins — that bridge the gap between neighbouring cell membranes, supported by cytoplasmic scaffold proteins including ZO-1. Together, these proteins form a continuous, belt-like seal around each cell, creating a regulated barrier to the passage of ions, water, and molecules through the spaces between cells (the paracellular route). Tight junctions do not form a complete seal — they are selectively permeable, and their permeability is controlled by the specific claudin proteins present and their functional state [Tsukita et al., 2001].
The proteins that form tight junctions are worth naming, not because the molecular biology is the story, but because the names appear frequently in skin barrier research and understanding what they are prevents confusion. Claudins are the primary structural proteins — there are multiple types, each with different permeability properties. Occludins are a second class of transmembrane protein; they contribute to junction stability and are regulators of paracellular permeability, though their precise role is still being characterised [Furuse et al., 1998]. ZO-1, ZO-2, and ZO-3 are scaffolding proteins on the inside of the cell membrane that anchor the transmembrane proteins in place and connect them to the cell's internal structure.
The practical point is this: tight junctions are not passive gaps waiting to be filled. They are actively maintained protein structures whose permeability is regulated by the cell and responsive to the cellular environment. When something disrupts that regulation — a detergent, an irritant, an inflammatory signal — tight junction permeability changes. The change is a physiological event, not a cosmetic one.
Where tight junctions are found in skin
Tight junctions are not located in the stratum corneum. They are found in the layer immediately beneath it — the stratum granulosum — and this location is what determines their function.
The epidermis — the outermost division of skin — is organised into layers. Cells are produced at the base, in the stratum basale, and move progressively outward over a cycle of approximately four weeks. As they travel, they differentiate: they change shape, accumulate proteins, release lipids, and eventually flatten completely into the corneocytes of the stratum corneum. The stratum corneum is the layer most people mean when they say "the skin barrier" — dead, anucleate cells embedded in a lipid matrix.
Tight junctions are not there. They are one layer below — in the stratum granulosum, the layer of living, granule-containing cells that sits immediately beneath the stratum corneum.
The stratum granulosum is the layer of living epidermal cells immediately below the stratum corneum. It is here that cells undergo the final stages of differentiation before flattening into corneocytes. The stratum granulosum is the site where lamellar bodies — the lipid-containing structures that will form the stratum corneum's lipid matrix — are released into the intercellular space. It is also the layer where tight junction proteins are expressed at highest density in the epidermis, forming a continuous belt-like seal between cells at this critical transition zone [Brandner et al., 2006].
The location is not incidental — it is functional. The stratum granulosum sits at the boundary between the living, metabolically active layers of the skin and the non-living stratum corneum above. It is at this boundary that the skin manages one of its most important regulatory tasks: controlling what moves from the deeper living tissue upward and outward through the dead outer layer. Tight junctions at this location form a second checkpoint — a living, regulated barrier at the interface between living and non-living skin.
The presence and functional significance of tight junctions in the stratum granulosum was not confirmed in human skin until 2002, when Furuse and colleagues demonstrated that claudin-1 and claudin-4 were expressed at high density in this layer, and that their disruption in mouse models produced measurable increases in paracellular permeability and water loss [Furuse et al., 2002]. Prior to this, the stratum corneum's lipid matrix had been treated as the sole barrier to permeability. The 2002 finding established that the skin's permeability regulation is a two-layer system — with tight junctions in the stratum granulosum providing a second, distinct line of regulation below the stratum corneum.
This is why tight junctions appear frequently in research on inflammatory skin conditions. Atopic dermatitis, psoriasis, and rosacea all involve disruption of the stratum granulosum and its tight junction integrity — not just disruption of the stratum corneum's lipid matrix. The disease pathology is located at the junction between living and non-living skin. Understanding where tight junctions sit is the first step to understanding what disruption of them produces.
What tight junctions do
Tight junctions regulate the paracellular route — the path between cells, as distinct from the path through them — controlling the passage of water, ions, and molecules at the stratum granulosum.
To understand what tight junctions do, it helps to understand what they are regulating. There are two routes by which anything can cross an epithelial or epidermal layer: through the cells (the transcellular route) or between the cells (the paracellular route). Tight junctions govern the paracellular route. That is their primary function.
In the stratum granulosum, the paracellular route is the space between living cells. Without tight junctions, that space would be an open channel — water, ions, and molecules could move freely between cells in either direction. Tight junctions seal those spaces selectively. They do not close them completely. They create a regulated gate: some molecules can pass, others cannot, and the permeability of the gate is determined by the composition and integrity of the tight junction protein complex.
Paracellular permeability refers to the passage of water, ions, and molecules through the spaces between cells — as opposed to through the cell membrane itself. In the stratum granulosum, tight junctions are the principal regulators of paracellular permeability. A tight junction barrier with normal integrity maintains selective, low permeability to most molecules. A compromised tight junction barrier — through altered claudin composition, protein degradation, or inflammatory signalling — has increased paracellular permeability, allowing larger molecules and greater water flux to move between cells than an intact junction would permit [Van Itallie and Anderson, 2004].
Tight junctions in the skin perform two directional functions simultaneously. They restrict the outward movement of water from the living epidermis through the stratum granulosum — contributing to water retention within the deeper layers. And they restrict the inward movement of environmental substances — allergens, microorganisms, irritants — from above the stratum granulosum into the living tissue below. Both directions of regulation depend on the same protein architecture.
"Tight junctions do not prevent movement — they govern it. The distinction is what makes them a regulatory system rather than a wall."
The specific claudin proteins present in the tight junction determine its selectivity. Different claudins have different channel properties — some are permeable to small cations, some restrict anion passage, some regulate water movement directly. In the skin, claudin-1 and claudin-4 are the primary tight junction claudins; claudin-1 in particular appears to be critical for barrier function — mice lacking claudin-1 die within one day of birth from uncontrolled water loss through the skin [Furuse et al., 2002]. This is not a marginal contribution. The selective permeability of the stratum granulosum tight junction is a physiologically essential function.
Tight junction permeability is not fixed — it is dynamically regulated. Inflammatory cytokines including TNF-α and IL-13 have been shown to alter claudin expression and tight junction organisation, increasing paracellular permeability in response to inflammatory signals [Proksch et al., 2008]. This means the tight junction barrier is responsive to the skin's immune environment — not just its physical environment. In conditions characterised by chronic low-grade inflammation, tight junction integrity can be continuously, progressively compromised by the same inflammatory mediators that drive other aspects of the disease pathology. This is part of the reason that barrier compromise in atopic dermatitis is difficult to reverse with purely topical approaches — the disruption is being maintained from within the tissue by inflammatory signals, not just from outside by chemical exposure.
Tight junctions vs. the lipid matrix
Tight junctions and the lipid matrix are not the same structure, not in the same location, and not performing the same function — but they regulate the same outcome.
The article on the lipid matrix explains in detail how the stratum corneum's organised ceramide, cholesterol, and free fatty acid layers create a structurally resistive pathway that slows passive water movement out of the body. That article is the starting point for understanding the stratum corneum as a physical barrier. This article answers the question that A4 implicitly raises: if the lipid matrix is the barrier, why do scientists also study tight junctions?
The answer is that the lipid matrix and tight junctions are not alternatives. They are sequential and complementary systems operating in different layers of the skin, by different mechanisms, against different aspects of the permeability problem.
| Dimension | Tight Junctions | Lipid Matrix |
|---|---|---|
| Location in skin | Stratum granulosum (living skin, below the stratum corneum) | Stratum corneum (non-living outer skin) |
| Structural nature | Protein complexes between cells (claudins, occludins, ZO proteins) | Organised lipid layers between cells (ceramides, cholesterol, free fatty acids) |
| Route regulated | Paracellular — between cells in living epidermis | Paracellular — between corneocytes in the dead outer layer |
| Mechanism | Selective protein gating — active, regulated permeability | Structural resistance — passive, architecture-based tortuosity |
| Cellular status | In living cells — metabolically active, protein-maintained | In non-living cells — lipid architecture maintained by prior synthesis |
| Water regulation direction | Outward (TEWL) and inward (environmental penetration) — bidirectional | Primarily outward — resists passive water loss via tortuosity |
| Response to inflammation | Directly regulated by inflammatory cytokines (TNF-α, IL-13) | Indirectly affected — inflammation impairs ceramide synthesis enzymes |
| Disrupted by surfactants | Yes — sustained anionic surfactant exposure is associated with tight junction disruption; the inflammatory signalling it produces is known to alter claudin and occludin expression [Proksch et al., 2008] | Yes — anionic surfactants extract structural lipids and disorganise matrix layers |
| Repaired by | Protein re-expression in living cells — days to weeks | Lipid synthesis and secretion from lamellar bodies — hours to days |
The most important distinction in the table above is mechanism. The lipid matrix works through architecture: it creates a physically tortuous path that water must navigate, and the organisation of that path determines how much water gets through. Tight junctions work through protein gating: they are active, maintained structures whose permeability is determined by their protein composition and can be regulated by cellular signals.
A useful way to think about the two systems: the lipid matrix is a labyrinth — its resistance comes from the complexity of the path. Tight junctions are a checkpoint — their control comes from the specificity of what is allowed through. Both exist in the skin simultaneously, and the skin's total regulatory capacity depends on both being intact.
"The stratum corneum and its lipid matrix have one answer to the permeability question. Tight junctions have a different answer. The barrier is not choosing between them — it requires both."
Tight junctions and water regulation
Tight junctions regulate the flow of water through the stratum granulosum — contributing to TEWL independently of the lipid matrix, and providing a second regulatory layer that the lipid matrix alone cannot replicate.
The stratum corneum's lipid matrix is the primary structural regulator of transepidermal water loss — the rate at which water vapour passes passively from the body through the skin to the surrounding environment. This is established in the literature and explained in detail in What Is TEWL. But the lipid matrix is not the only layer of regulation. Below it, tight junctions in the stratum granulosum regulate the movement of water across the living epidermis before water reaches the stratum corneum at all.
The evidence for the tight junction's role in water regulation comes from multiple sources. The claudin-1 knockout finding — mice lacking claudin-1 die within hours from uncontrolled water loss — is the most dramatic: it demonstrates that tight junction integrity at the stratum granulosum is non-negotiable for survival [Furuse et al., 2002]. More subtle evidence comes from lanthanum tracer studies, in which a small, electron-dense molecule is applied to the skin surface and its penetration depth is tracked under electron microscopy. In intact skin, lanthanum penetrates the stratum corneum but is blocked at the tight junction zone of the stratum granulosum — showing that tight junctions form a second physical barrier to downward penetration that the stratum corneum alone does not provide [Yoshida et al., 2013].
Tight junctions contribute to what researchers describe as the "inside-out" barrier — regulating the movement of water and solutes outward from the viable epidermis into the non-living stratum corneum above. When tight junctions are intact, they restrict the rate at which water moves from the stratum granulosum upward — helping to maintain adequate water content within the deeper living skin layers. When tight junctions are disrupted, water flux through the living epidermis accelerates. This elevated flux reaches the stratum corneum, where even an intact lipid matrix may be insufficient to prevent a measurable increase in TEWL — because the rate of water arriving from below has increased beyond what the lipid matrix's tortuosity can fully resist. The two systems are therefore additive in their regulatory effect: total TEWL regulation requires both to be functional [Brandner et al., 2006].
This additive relationship has practical implications. A skin that has maintained its stratum corneum lipid architecture but sustained tight junction disruption in the stratum granulosum will still show elevated TEWL — not because the lipid matrix has failed, but because the upstream water flux regulation has been compromised. Conversely, a skin that has recovered lipid matrix organisation may still experience elevated baseline water loss if tight junction protein expression has not normalised. The two systems operate in series, and the total output of the series depends on both.
What happens when tight junctions are disrupted
Tight junction disruption increases paracellular permeability in both directions — accelerating water loss outward and allowing environmental substances easier access inward. The consequences are not always immediate or obvious.
Tight junction disruption does not produce a single, dramatic symptom. Like lipid matrix disorganisation, it produces a sequence of consequences that unfold across different timescales and can be difficult to trace back to their structural origin. The most direct consequence — increased paracellular permeability — is a physiological change, not an experience. The experiences that follow from it may appear to be separate events.
The outward consequence is accelerated water flux. When the tight junction barrier at the stratum granulosum is compromised, water moves more freely from the viable epidermis upward. This increased flux is an upstream contribution to TEWL — before water even reaches the lipid matrix, more of it is moving through the living skin than an intact tight junction would permit. In mild disruption, the lipid matrix may compensate. In sustained or severe disruption, both systems show elevated water loss simultaneously.
The inward consequence is the one that more directly drives the experiences associated with sensitive and reactive skin. The same tight junction architecture that restricts water loss also restricts the inward penetration of molecules from the stratum corneum into the living epidermis. When tight junctions are compromised, this restriction is reduced. Environmental irritants — residual surfactant molecules, airborne particulates, microbial fragments — can penetrate more deeply into the epidermis and reach the immune cells that reside in the living skin layers.
The living epidermis contains Langerhans cells — epidermal dendritic cells that function as the skin's first line of immune surveillance. In normal circumstances, the combination of the stratum corneum's lipid matrix and the tight junction barrier at the stratum granulosum limits the access of environmental antigens and irritants to these immune cells. When tight junction integrity is compromised, this access increases. Antigens that would otherwise remain confined to the non-living stratum corneum are now able to penetrate to the Langerhans cell level. This can trigger immune activation — including IgE sensitisation in genetically predisposed individuals — and produces or amplifies the inflammatory response that characterises atopic dermatitis, contact dermatitis, and other barrier-disruption-associated conditions [Proksch et al., 2008]. The tight junction, in this context, is not just a physical barrier — it is an immune checkpoint.
The causes of tight junction disruption in skin are several, and they are not all external. Anionic surfactants — the dominant cleansing class in most face washes — are established to deplete structural lipids from the stratum corneum and elevate TEWL; the inflammatory signalling generated by sustained surfactant exposure is known to alter claudin and occludin expression, implicating repeated anionic surfactant contact as an indirect stressor on tight junction integrity [Proksch et al., 2008]. Inflammatory cytokines produced during any inflammatory response — including the low-grade chronic inflammation that accompanies barrier disruption — alter claudin composition and increase paracellular permeability from within. Age reduces the density and organisation of tight junction proteins as part of the broader decline in epidermal function that affects ceramide synthesis, NMF content, and desquamation regulation. And genetic variants affecting claudin expression — particularly in atopic dermatitis — can mean that tight junction integrity is structurally compromised from baseline, independent of environmental exposures.
The clinical picture of tight junction disruption is often indistinguishable from the clinical picture of lipid matrix disruption: increased TEWL, tightness, heightened reactivity, reduced tolerance of previously tolerated products. The two systems are so closely linked in their functional outputs that disruption of either produces similar surface experiences. The distinction matters primarily in understanding which layer of the barrier has been compromised — and therefore what conditions are required for recovery.
Why the barrier requires both systems
The skin barrier is not a single structure. It is an overlapping architecture of complementary regulatory systems — and its functional integrity depends on the contribution of each.
The conventional representation of the skin barrier in skincare education is the stratum corneum: flat cells embedded in a lipid matrix, regulating what passes in and out. That representation is not wrong — it describes a real and critical system. But it is incomplete in a way that matters for understanding how barrier disruption occurs, why certain skin conditions resist topical treatment, and why the barrier's total regulatory capacity is greater than any single layer can achieve alone.
The skin barrier is better understood as a layered architecture: the lipid matrix of the stratum corneum as the outermost, passive, architecture-dependent layer; the tight junctions of the stratum granulosum as a second, active, protein-dependent layer below it. Both layers regulate permeability in both directions. Both layers can be disrupted by overlapping causes — surfactants, inflammation, age, genetic variation. Both layers are needed for the system as a whole to function at its full regulatory capacity.
The research that established tight junctions as a functional epidermal barrier component changed how we think about what the barrier is. Before it, barrier science was primarily a lipid story — ceramides, cholesterol, fatty acids, and their organisation. After it, barrier science became a systems question: two distinct structural systems, in two distinct locations, regulated by two distinct mechanisms, producing a single integrated output. The practical consequence is that any approach to barrier disruption that treats the stratum corneum as the whole story is addressing a partial problem with a partial solution. The tight junction layer is not a bonus feature — it is load-bearing.
Scientists study both systems together because the evidence shows that they fail together. In atopic dermatitis — the best-characterised barrier-disruption skin condition — both systems are compromised simultaneously: the stratum corneum shows reduced ceramide levels and impaired lipid organisation, and the stratum granulosum shows reduced claudin-1 expression and disrupted tight junction architecture [De Benedetto et al., 2011]. The two disruptions amplify each other. A lipid matrix that is compromised allows more environmental substances to reach the tight junction layer; a tight junction layer that is compromised allows more of those substances to reach the immune cells that produce the inflammatory signals that further impair both lipid synthesis and tight junction protein expression. The loop is not between two independent systems — it is between two components of the same integrated barrier.
This is why single-component barrier approaches — ceramide supplementation alone, or any intervention that addresses only one layer of the barrier's architecture — have a structural ceiling on what they can achieve. The barrier is not asking for one input. It is asking for conditions under which all of its overlapping systems can maintain or restore their integrity. That is a different, and more demanding, question.
Formulation context — Cedar of the Forest
The evidence that the skin barrier is a two-system architecture — lipid matrix in the stratum corneum, tight junctions in the stratum granulosum — shaped the question that Cedar of the Forest was built to answer. If both systems are vulnerable to the same disrupting inputs, and if daily cleansing is the most frequent, most concentrated exposure to those inputs, then the cleansing step is not a cosmetically neutral act. It is the routine's most significant structural event for both barrier layers simultaneously.
Anionic surfactants — the dominant cleansing class in most face washes — have documented effects on the lipid matrix: they extract structural lipids from the stratum corneum and elevate TEWL. The inflammatory signalling that sustained surfactant exposure produces is also known to alter claudin and occludin expression, placing repeated anionic surfactant contact among the indirect stressors on tight junction integrity. Cedar was formulated to cleanse through oil-phase dissolution and non-ionic emulsification, rather than through anionic surfactant interaction with the barrier's structural components. The objective was not to avoid cleansing. It was to cleanse without making the structural environment worse — to create conditions in which both barrier layers could maintain their integrity rather than requiring repair after every wash.
- Cleansing mechanismOil-phase dissolution of sebum, sunscreen, and debris — removal without anionic surfactant interaction with barrier lipids or tight junction proteins
- Emulsification systemNon-ionic emulsifiers for rinse behaviour — different interaction profile with stratum corneum lipids compared to anionic surfactant systems
- pH designFormulated toward the skin's physiological acid mantle range — supporting the enzymatic environment that ceramide synthesis and tight junction maintenance depend on
Frequently Asked Questions
What are tight junctions in skin?
Tight junctions are multiprotein complexes that form at the contact zone between adjacent cells in the stratum granulosum — the layer of living skin immediately below the stratum corneum. They are composed primarily of claudin and occludin transmembrane proteins, anchored by scaffolding proteins on the cell's inner membrane. Their function is to regulate paracellular permeability: the passage of water, ions, and molecules through the spaces between cells. In skin, they form a continuous, belt-like seal around each cell in the stratum granulosum, creating a second, distinct barrier layer below the stratum corneum's lipid matrix.
Where are tight junctions found in the skin?
Tight junctions in the skin are located primarily in the stratum granulosum — the layer of living, granule-containing epidermal cells that sits directly beneath the stratum corneum. They are not found in the stratum corneum itself, which is composed of non-living cells. The stratum granulosum location is functionally significant: it places the tight junction barrier at the transition point between living and non-living skin, where it can regulate what passes upward from the viable epidermis into the outer skin layer and what penetrates downward from the stratum corneum into the living tissue below.
How are tight junctions different from the lipid matrix?
Tight junctions and the lipid matrix are distinct in location, composition, and mechanism. The lipid matrix is located in the stratum corneum (non-living outer skin), is composed of organised ceramide, cholesterol, and free fatty acid layers, and works through structural resistance — creating a tortuous physical path that slows water movement by architecture. Tight junctions are located in the stratum granulosum (living skin, one layer below), are composed of claudin and occludin proteins, and work through active protein gating — selectively regulating what passes between living cells based on the composition and integrity of the junction protein complex. Both systems regulate permeability. Neither system substitutes for the other.
What happens when tight junctions are disrupted?
Disrupted tight junctions increase paracellular permeability in both directions. Outward: water moves more freely from the living epidermis through the stratum granulosum, contributing to elevated transepidermal water loss (TEWL) independently of the lipid matrix. Inward: environmental substances — irritants, allergens, microbial fragments — can penetrate more deeply into the skin and reach immune cells in the living tissue, increasing the likelihood of immune activation and inflammatory responses. The surface experiences — elevated TEWL, tightness, reactivity — can closely resemble the experiences produced by lipid matrix disruption, because both systems regulate the same overall outcome.
What controls tight junction permeability in skin?
Tight junction permeability in skin is controlled by the composition and integrity of the claudin proteins present in the junction complex. Different claudin types have different permeability properties. In addition to this structural control, tight junction permeability is dynamically regulated by inflammatory signals: cytokines including TNF-α and IL-13 alter claudin expression and can increase paracellular permeability in response to inflammatory conditions. Sustained anionic surfactant exposure is an established cause of lipid matrix disruption and TEWL elevation; the inflammatory signalling it generates can in turn compromise tight junction integrity through those same cytokine-mediated pathways [Proksch et al., 2008].
Do tight junctions contribute to transepidermal water loss?
Yes. Tight junctions regulate the rate at which water moves from the viable epidermis upward through the stratum granulosum — the layer below the stratum corneum. When tight junction integrity is compromised, this flux increases, contributing to elevated TEWL independently of the lipid matrix. The two systems are additive in their regulatory effect: total TEWL regulation requires both the lipid matrix and the tight junction barrier to be functional. Evidence for the tight junction's role in water regulation comes from claudin-1 knockout studies, in which the absence of this single tight junction protein produced lethal levels of water loss within hours of birth [Furuse et al., 2002].
Are tight junctions relevant to atopic dermatitis?
Yes. Atopic dermatitis involves simultaneous disruption of both the stratum corneum lipid matrix and the stratum granulosum tight junction layer. Reduced claudin-1 expression has been demonstrated in atopic dermatitis skin [De Benedetto et al., 2011], alongside the ceramide depletion and lipid disorganisation that are more widely known features of the condition. The two disruptions interact: compromised tight junctions allow allergens and irritants greater access to the immune cells of the living epidermis, driving the inflammatory responses that further impair both lipid synthesis and tight junction protein expression. This is part of why atopic dermatitis barrier disruption can be persistent despite topical lipid supplementation alone.
Why does skincare talk about ceramides but not tight junctions?
The commercial skincare conversation has largely focused on ceramides because they are an ingredient — something that can be added to a formulation, measured, and communicated to consumers. Tight junctions are a protein system within living skin cells that cannot be directly supplemented through topical application in the same way. The scientific understanding of tight junctions as a functional epidermal barrier component only became established in the early 2000s, whereas the lipid matrix has been studied since the 1980s. The practical relevance of tight junction science for product formulation lies not in supplementation but in avoiding the exposures — particularly sustained anionic surfactant contact — that have been shown to compromise tight junction integrity.
- Tsukita, S., Furuse, M., and Itoh, M. "Multifunctional strands in tight junctions." Nature Reviews Molecular Cell Biology, Vol. 2, No. 4, 2001, pp. 285–293.
- Furuse, M., Hata, M., Furuse, K., et al. "Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice." Journal of Cell Biology, Vol. 156, No. 6, 2002, pp. 1099–1111.
- Furuse, M., Hirase, T., Itoh, M., et al. "Occludin: a novel integral membrane protein localizing at tight junctions." Journal of Cell Biology, Vol. 123, No. 6, 1993, pp. 1777–1788.
- Van Itallie, C.M., and Anderson, J.M. "The molecular physiology of tight junction pores." Physiology, Vol. 19, No. 6, 2004, pp. 331–338.
- Brandner, J.M., Kief, S., Grund, C., et al. "Organization and formation of the tight junction system in human epidermis and cultured keratinocytes." European Journal of Cell Biology, Vol. 81, No. 5, 2002, pp. 253–263.
- Brandner, J.M. "Tight junctions and tight junction proteins in mammalian epidermis." European Journal of Pharmaceutics and Biopharmaceutics, Vol. 72, No. 2, 2009, pp. 289–294.
- Yoshida, K., Yokouchi, M., Nagao, K., et al. "Functional tight junction barrier localizes in the second layer of the stratum granulosum of human epidermis." Journal of Dermatological Science, Vol. 71, No. 2, 2013, pp. 89–99.
- Proksch, E., Brandner, J.M., and Jensen, J.M. "The skin: an indispensable barrier." Experimental Dermatology, Vol. 17, No. 12, 2008, pp. 1063–1072.
- De Benedetto, A., Rafaels, N.M., McGirt, L.Y., et al. "Tight junction defects in patients with atopic dermatitis." Journal of Allergy and Clinical Immunology, Vol. 127, No. 3, 2011, pp. 773–786.
- Elias, P.M. "Stratum corneum defensive functions: an integrated view." Journal of Investigative Dermatology, Vol. 125, No. 2, 2005, pp. 183–200.
- Pinnagoda, J., Tupker, R.A., Agner, T., and Serup, J. "Guidelines for transepidermal water loss (TEWL) measurement." Contact Dermatitis, Vol. 22, No. 3, 1990, pp. 164–178.